LEXEO THERAPEUTICS INC LXEO

US Healthcare Biological Products, (No Diagnostic Substances)
$4.69
+5.4%
52w: $3.67 – $10.63

Latest 13F among current holders filed 11 days ago (Jun 24, 2026)

Price — last 12 months

research preview data
3.677.1510.63
Jun 20, 2025 Jul 2, 2026
Institutional holders
139
-7 QoQ
13F value
$458.7M
-39.6% QoQ
Smart-money holders
15
signal tier ≥ 2
New smart buyers
0
Q1 2026
Options barometer
6.4×
$389K calls / $60K puts

Institutional value by quarter

$370.0M
Q1 2024
$426.2M
Q2 2024
$269.7M
Q3 2024
$194.2M
Q4 2024
$100.0M
Q1 2025
$169.9M
Q2 2025
$327.6M
Q3 2025
$759.2M
Q4 2025
$458.7M
Q1 2026

Number of holders

55
Q1 2024
60
Q2 2024
70
Q3 2024
91
Q4 2024
89
Q1 2025
91
Q2 2025
109
Q3 2025
146
Q4 2025
139
Q1 2026

Who owns LXEO?

Q1 2026 filings
FundTypeSharesValue% of fundChange
Paradigm Biocapital Advisors LP ★2Fundamental concentrated6.2M$35.5M0.7%+29.8%
BlackRock, Inc. Index provider5.1M$29.3M0.0%+4.1%
Affinity Asset Advisors, LLC ★2Fundamental diversified5.1M$29.0M1.7%+57.8%
RA CAPITAL MANAGEMENT, L.P. ★2Fundamental diversified5.0M$28.7M0.3%Held
JANUS HENDERSON GROUP PLC Diversified mechanical5.0M$28.5M0.0%-9.7%
Vestal Point Capital, LP ★2Fundamental diversified4.5M$25.7M0.7%Held
Frazier Life Sciences Management, L.P. ★3Fundamental concentrated4.4M$25.4M0.7%Held
CITADEL ADVISORS LLC Multistrat pod3.8M$22.0M0.0%+1.6%
ORBIMED ADVISORS LLC ★2Fundamental diversified3.6M$20.7M0.5%+69.5%
STATE STREET CORP Index provider3.6M$20.5M0.0%+11.9%
VANGUARD CAPITAL MANAGEMENT LLC Diversified mechanical3.0M$17.3M0.0%
Woodline Partners LP Other2.8M$15.8M0.1%-14.0%
GOLDMAN SACHS GROUP INC Bank broker1.9M$11.2M0.0%+149.4%
Avoro Capital Advisors LLC ★3Fundamental concentrated1.9M$10.8M0.1%-43.2%
Point72 Asset Management, L.P. Multistrat pod1.7M$9.6M0.0%-11.3%
MILLENNIUM MANAGEMENT LLC Multistrat pod1.6M$9.3M0.0%+77.6%
Balyasny Asset Management L.P. Multistrat pod1.6M$9.1M0.0%-2.8%
GEODE CAPITAL MANAGEMENT, LLC Index provider1.5M$8.7M0.0%+4.7%
ADAR1 Capital Management, LLC Other1.5M$8.4M0.5%+5.3%
SUVRETTA CAPITAL MANAGEMENT, LLC ★2Fundamental diversified1.3M$7.2M0.2%Held
Nantahala Capital Management, LLC ★2Fundamental diversified1.2M$6.9M0.4%+20.0%
683 Capital Management, LLC ★2Fundamental diversified1.2M$6.9M0.7%+7.1%
DIMENSIONAL FUND ADVISORS LP Quant stat arb1.1M$6.3M0.0%+27.9%
Octagon Capital Advisors LP ★2Fundamental concentrated1.1M$6.3M0.7%-36.2%
Spruce Street Capital LP ★2Fundamental concentrated928.6K$5.3M1.3%+430.6%
Blackstone Inc. Other905.0K$5.2M0.0%Held
VANGUARD PORTFOLIO MANAGEMENT LLC Diversified mechanical577.2K$3.3M0.0%
Ikarian Capital, LLC ★2Fundamental diversified513.0K$2.9M0.4%Held
NORTHERN TRUST CORP Index provider493.7K$2.8M0.0%+8.0%
BANK OF AMERICA CORP /DE/ Bank broker491.5K$2.8M0.0%+206.7%
Qube Research & Technologies Ltd Quant stat arb465.5K$2.7M0.0%+249.3%
MORGAN STANLEY Bank broker402.9K$2.3M0.0%+187.4%
VANGUARD FIDUCIARY TRUST CO Diversified mechanical384.7K$2.2M0.0%
DAFNA Capital Management LLC ★2Fundamental diversified377.1K$2.2M0.5%+10.6%
AQR CAPITAL MANAGEMENT LLC Quant stat arb339.6K$1.9M0.0%+0.7%
UBS Group AG Bank broker321.7K$1.8M0.0%+14.5%
Squarepoint Ops LLC Quant stat arb319.1K$1.8M0.0%+244.6%
Aberdeen Group plc Other245.9K$1.4M0.0%New
BNP PARIBAS FINANCIAL MARKETS Bank broker228.2K$1.3M0.0%-11.3%
Privium Fund Management B.V. ★2Fundamental diversified205.0K$1.2M0.2%+6.5%
Nuveen, LLC Diversified mechanical183.0K$1.1M0.0%-13.5%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC Index provider182.1K$1.0M0.0%-5.3%
TWO SIGMA INVESTMENTS, LP Quant stat arb181.7K$1.0M0.0%-54.6%
WELLINGTON MANAGEMENT GROUP LLP Long only active172.7K$991K0.0%+107.5%
Bank of New York Mellon Corp Diversified mechanical158.9K$912K0.0%-4.7%
Y-Intercept (Hong Kong) Ltd Diversified mechanical142.6K$818K0.0%-38.3%
BOOTHBAY FUND MANAGEMENT, LLC Diversified mechanical136.4K$783K0.0%Held
Burkehill Global Management, LP Quant stat arb125.0K$718K0.0%Held
Susquehanna Portfolio Strategies, LLC Market maker113.0K$649K0.0%+331.1%
ExodusPoint Capital Management, LP Multistrat pod112.2K$644K0.0%New

Exits are not a bearish signal: our backtest shows stocks specialists exit keep outperforming for 3+ quarters — selling usually means profit-taking, not a forecast.